Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes

OBJECTIVE: The high degree of clinical overlap between atypical parkinsonian syndromes (APS) and Parkinson’s disease (PD) makes diagnosis challenging. We aimed to identify novel diagnostic protein biomarkers of APS using multiplex proximity extension assay (PEA) testing. METHODS: Cerebrospinal fluid...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabbari, Edwin, Woodside, John, Guo, Tong, Magdalinou, Nadia K, Chelban, Viorica, Athauda, Dilan, Lees, Andrew J, Foltynie, Thomas, Houlden, Henry, Church, Alistair, Hu, Michele TM, Rowe, James B, Zetterberg, Henrik, Morris, Huw R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Movement Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585258/
https://www.ncbi.nlm.nih.gov/pubmed/30867224
http://dx.doi.org/10.1136/jnnp-2018-320151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585258/
https://www.ncbi.nlm.nih.gov/pubmed/30867224
http://dx.doi.org/10.1136/jnnp-2018-320151

Ejemplares similares